Perkins SD - Search Results

1

Perkins SD, Smither SJ, Atkins HS. Perkins SD, et al. FEMS Microbiol Rev. 2010 May;34(3):379-94. doi: 10.1111/j.1574-6976.2010.00211.x. Epub 2010 Jan 19. FEMS Microbiol Rev. 2010. PMID: 20180858 Free article. Review.

2

Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suis.

Smither SJ, Perkins SD, Davies C, Stagg AJ, Nelson M, Atkins HS. Smither SJ, et al. Among authors: perkins sd. Clin Vaccine Immunol. 2009 May;16(5):779-83. doi: 10.1128/CVI.00029-09. Epub 2009 Mar 25. Clin Vaccine Immunol. 2009. PMID: 19321692 Free PMC article.

3

Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse.

O'Brien LM, Stokes MG, Lonsdale SG, Maslowski DR, Smither SJ, Lever MS, Laws TR, Perkins SD. O'Brien LM, et al. Among authors: perkins sd. Virology. 2014 Mar;452-453:324-33. doi: 10.1016/j.virol.2013.03.028. Epub 2014 Jan 24. Virology. 2014. PMID: 24461913 Free article.

4

Alpha interferon as an adenovirus-vectored vaccine adjuvant and antiviral in Venezuelan equine encephalitis virus infection.

O'Brien L, Perkins S, Williams A, Eastaugh L, Phelps A, Wu J, Phillpotts R. O'Brien L, et al. J Gen Virol. 2009 Apr;90(Pt 4):874-882. doi: 10.1099/vir.0.006833-0. Epub 2009 Mar 4. J Gen Virol. 2009. PMID: 19264673

5

A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice.

Morton M, Garmory HS, Perkins SD, O'Dowd AM, Griffin KF, Turner AK, Bennett AM, Titball RW. Morton M, et al. Among authors: perkins sd. Vaccine. 2004 Jun 30;22(20):2524-32. doi: 10.1016/j.vaccine.2004.01.007. Vaccine. 2004. PMID: 15193377

6

CpG used as an adjuvant for an adenovirus-based Venezuelan equine encephalitis virus vaccine increases the immune response to the vector, but not to the transgene product.

Perkins SD, Williams AJ, O'Brien LM, Laws TR, Phillpotts RJ. Perkins SD, et al. Viral Immunol. 2008 Dec;21(4):451-7. doi: 10.1089/vim.2008.0052. Viral Immunol. 2008. PMID: 19115934

7

A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus.

Goodchild SA, O'Brien LM, Steven J, Muller MR, Lanning OJ, Logue CH, D'Elia RV, Phillpotts RJ, Perkins SD. Goodchild SA, et al. Among authors: perkins sd. Antiviral Res. 2011 Apr;90(1):1-8. doi: 10.1016/j.antiviral.2011.01.010. Epub 2011 Feb 15. Antiviral Res. 2011. PMID: 21310183

8

DNA vaccines for biodefence.

Garmory HS, Perkins SD, Phillpotts RJ, Titball RW. Garmory HS, et al. Among authors: perkins sd. Adv Drug Deliv Rev. 2005 Jun 17;57(9):1343-61. doi: 10.1016/j.addr.2005.01.013. Epub 2005 Apr 13. Adv Drug Deliv Rev. 2005. PMID: 15935877 Review.

9

Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination.

Perkins SD, O'Brien LM, Phillpotts RJ. Perkins SD, et al. Vaccine. 2006 Apr 24;24(17):3440-5. doi: 10.1016/j.vaccine.2006.02.020. Epub 2006 Feb 21. Vaccine. 2006. PMID: 16527377

10

Improved efficacy of a gene optimised adenovirus-based vaccine for venezuelan equine encephalitis virus.

Williams AJ, O'Brien LM, Phillpotts RJ, Perkins SD. Williams AJ, et al. Among authors: perkins sd. Virol J. 2009 Jul 31;6:118. doi: 10.1186/1743-422X-6-118. Virol J. 2009. PMID: 19646224 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page